MYASTHENIA GRAVIS (MG)
Clinical trials for MYASTHENIA GRAVIS (MG) explained in plain language.
Never miss a new study
Get alerted when new MYASTHENIA GRAVIS (MG) trials appear
Sign up with your email to follow new studies for MYASTHENIA GRAVIS (MG), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at autoimmune diseases
Disease control Not yet recruitingThis early-stage study is testing a new treatment called C-CAR168 for people with autoimmune diseases like multiple sclerosis, lupus, and myasthenia gravis that have not improved with standard therapies. The treatment uses a patient's own immune cells, which are modified in a lab…
Matched conditions: MYASTHENIA GRAVIS (MG)
Phase: PHASE1 • Sponsor: The Affiliated Hospital of Qingdao University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug aims to ease daily struggles of myasthenia gravis
Disease control Not yet recruitingThis study tests an experimental drug called empasiprubart in people with a specific type of generalized myasthenia gravis (gMG) who have AChR antibodies. The goal is to see if the drug is safe and can improve symptoms like muscle weakness that affect daily activities. Participan…
Matched conditions: MYASTHENIA GRAVIS (MG)
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug MTM-H-001 targets B-Cell autoimmune diseases in early trial
Disease control Not yet recruitingThis early study tests a new drug called MTM-H-001 in 75 adults with B-cell-related autoimmune diseases, including lupus, multiple sclerosis, and rheumatoid arthritis. The main goal is to check safety and find the right dose. Participants receive the drug by injection, and resear…
Matched conditions: MYASTHENIA GRAVIS (MG)
Phase: NA • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Experimental drug talquetamab takes aim at stubborn myasthenia gravis
Disease control Not yet recruitingThis very early study will test the drug talquetamab in just 2 people with refractory generalized myasthenia gravis, a chronic autoimmune disease that causes muscle weakness. The drug is designed to help the immune system attack the cells that produce harmful antibodies. The goal…
Matched conditions: MYASTHENIA GRAVIS (MG)
Phase: NA • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug ripertamab tested for muscle weakness disease
Disease control Not yet recruitingThis early-stage trial tests whether a single infusion of ripertamab can safely improve daily living activities in 20 adults with generalized myasthenia gravis, a condition causing muscle weakness. Participants are randomly assigned to receive the drug or a placebo, and are follo…
Matched conditions: MYASTHENIA GRAVIS (MG)
Phase: PHASE1, PHASE2 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can learning to manage stress ease the burden of myasthenia gravis?
Symptom relief Not yet recruitingThis study aims to see if a stress management program can help adults with myasthenia gravis feel less anxious and stressed, and improve their quality of life. About 62 participants will take part in an 8-session program and report their symptoms before and after. The goal is to …
Matched conditions: MYASTHENIA GRAVIS (MG)
Sponsor: University Hospital, Grenoble • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Hidden toll of myasthenia gravis: study probes sexual and bladder problems often overlooked
Knowledge-focused Not yet recruitingThis study investigates sexual and urinary problems in people with generalized myasthenia gravis, an autoimmune disease that causes muscle weakness. While visible symptoms like droopy eyelids are well-known, issues like sexual dysfunction and bladder problems are often ignored. R…
Matched conditions: MYASTHENIA GRAVIS (MG)
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 02, 2026 06:00 UTC
-
New study aims to uncover hidden clues in myasthenia gravis
Knowledge-focused Not yet recruitingThis observational study will follow 40 adults with thymic abnormalities or myasthenia gravis (MG)-related antibodies to better understand how the disease develops and progresses. Researchers will analyze blood, thymus tissue, and muscle samples, along with clinical assessments, …
Matched conditions: MYASTHENIA GRAVIS (MG)
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC